3M (NYSE:MMM) said yesterday that its board of directors nominated CEO Mike Roman as its new chairperson, with current exec chair Inge Thulin announcing their intention to retire. The move is slated to take effect following the St. Paul, Minn.-based company’s annual meeting of shareholders on May 14. “Under Inge’s leadership, 3M evolved into a more […]
Misonix
NASS 2017 Roundup: Zimmer Biomet launches Vitality+, Vital spinal fixation systems
Zimmer Biomet (NYSE:ZBH) today announced the launch of its Vitality+ and Vital spine fixation systems in the US following recent 510(k) clearance for pedicle preparation and screw insertion under power. The Vitality+ spinal fixation system is composed of a Vitality+ Power designed for controlled pedicle preparation and pedicle screw insertion, Vitality+ PSO designed for optimal pedicle […]
Misonix inks $11m Chinese licensing, manufacturing deal for SonaStar
Misonix (NSDQ:MSON) said today it inked an $11 million licensing and exclusive manufacturing deal with Chinese Hunan Xing Hang Rui Kang Bio-Technologies for Misonix’s SonaStar product line in China, Hong Kong and Macau. Through the agreement, Misonix will receive $5 million in upfront technology license fees and stocking orders as well as minimum royalty payments from […]
Neuros Medical taps ex-Sequent CEO Wilder for corner office | Personnel Moves, August 28, 2017
Neuros Medical said it named Tom Wilder, the CEO who led Sequent Medical to a $280 million acquisition by Terumo Corp. (TYO:4543), to take the corner office. “Neuros Medical, with its patented Altius system high-frequency nerve block technology, has the opportunity to develop important therapy options for patients who experience significant pain as a result […]
Misonix inks Chinese distro deal for BoneScalpel with Weigao Orthopedic
Misonix (NSDQ:MSON) said today it inked an exclusive distribution agreement with Shandong Weigao Orthopedic Device Company. Through the deal, Weigao Orthopedic will gain the rights to sell, market and distribute Farmingdale, N.Y.-based Misonix’s BoneScalpel in China, Hong Kong and Macau for an initial period of 5-years. “We are pleased to enter into this distribution agreement with […]
Zimmer Biomet elevates Delp to Americas prez | Personnel Moves | January 22, 2017
Zimmer Biomet (NYSE:ZBH) said this week it tapped Robert Delp as its new Americas president, lifting him from his previous position as VP of US sales. Delp will replace former Americas prez Stuart Kleopfer, who is retiring from the position but will continue to work with the company while Delp transitions into his position. The shift […]
Misonix shares slightly up despite missing Q1 filing deadline
Misonix (NSDQ:MSON) today saw shares rise slightly despite saying it will miss the filing deadline for its quarterly report due to an ongoing investigation, according to an SEC filing posted today. The filing follows a delayed annual report from the company that came through in June, Misonix said, due to an investigation from the audit committee […]
Misonix interim CEO Vizirgianakis puts $4m into company
Misonix (NSDQ:MSON) said today its interim CEO Stavros Vizirgianakis invested $4 million into the company through the purchase of 761,469 shares at $5.25 per share. The shares purchased are considered to be “restricted shares,” as they were acquired in a transaction not involving a public offering. The shares, therefore, cannot be sold without appropriate registration under […]
Misonix CEO steps down | Personnel Moves October 4, 2016
Misonix CEO steps down Misonix (NSDQ:MSON) CEO Michael McManus, Jr. stepped down in early September, also leaving his post as director and chairman of the board of directors. Stavros Vizirgianakis, a member of the board of directors, is serving as the interim CEO while negotiating for a full-time position in the corner office. Vizirgiankis, who owned […]
Misonix reports Chinese distributor to SEC, DOJ over possible FCPA issues
Misonix (NSDQ:MSON) this week reached out to the Securities and Exchange Commission and the U.S. Department of Justice over possible issues with the Chinese distributor of its products, according to an SEC filing posted today. The company said that on Sept. 27 and Sept. 28, respectively, it contacted the SEC and DOJ to “voluntarily inform” them that […]
Misonix delays annual report, taps Dwyer as interim CFO
Misonix (NSDQ:MSON) said today that it delayed its annual report due to “deficiencies” in its internal financial reporting controls and posted a swing to red ink for fiscal 2016. The Farmingdale, N.Y.-based company also said it named Joseph Dwyer as interim CFO, replacing Richard Zaremba, who was named senior finance VP. “The filing stated that the audit committee […]